AG
Arunoday Gupta
About Arunoday Gupta
Data last updated:
Arunoday Gupta is a Designated Partner at Genorix Llp (since 2026), Director at Vertex Pharmaceuticals Industries Private Limited (since 2023) and Designated Partner at Medisave Formulations India Llp (since 2022). The companies operate in Pharma and Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genorix Llp ADA-9354 | Designated Partner | 06 Aug 2026 | 2026 | Active | |
| Vertex Pharmaceuticals Industries Private Limited U46909DL2023PTC421460 | Director | 16 Oct 2023 | 2023 | Active | |
| Medisave Formulations India Llp ABA-5633 | Designated Partner | 09 Feb 2022 | 2022 | Active |
Board colleagues of Arunoday Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Aggarwal | 00171722 | Genorix Llp , Vertex Pharmaceuticals Industries Private Limited and 1 more | Designated Partner |
| Ashok Jain | 01852674 | Vertex Pharmaceuticals Industries Private Limited , Medisave Formulations India Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arunoday Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arunoday Gupta
Arunoday Gupta currently holds 3 directorships: Genorix Llp (Designated Partner, since 06 Aug 2026); Vertex Pharmaceuticals Industries Private Limited (Director, since 16 Oct 2023); Medisave Formulations India Llp (Designated Partner, since 09 Feb 2022).
Arunoday Gupta was first appointed on 09 Feb 2022 as Designated Partner at Medisave Formulations India Llp. The most recent appointment on record is 06 Aug 2026 at Genorix Llp.
The current boards of Arunoday Gupta's companies include Manish Aggarwal (Genorix Llp), Ashok Jain (Vertex Pharmaceuticals Industries Private Limited).